
We performed an individual patient-level meta-analysis including three GP/HR studies (n=17,903 participants) and three CKD studies (n=5415). Serum β-trace protein (BTP) and β-2 microglobulin (B2M) are associated with risk of ESRD and death in the general population and in populations at high risk for these outcomes (GP/HR) and those with CKD, but results differ among studies.ĭesign, setting, participants, & measurements:

9 Boston University School of Medicine, Boston, Massachusetts.8 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland and.

7 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.6 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona.5 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.

